Related references
Note: Only part of the references are listed.The Efficacy of Omega-3 Supplementation for Major Depression: A Randomized Controlled Trial
Francois Lesperance et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Meta-Analysis of the Effects of Eicosapentaenoic Acid (EPA) in Clinical Trials in Depression
M. Elizabeth Sublette et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood
Katherine M. Appleton et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2010)
Eicosapentaenoic acid as an add-on to antidepressant medication for co-morbid major depression in patients with diabetes mellitus: A randomized, double-blind placebo-controlled study
M. Bot et al.
JOURNAL OF AFFECTIVE DISORDERS (2010)
Effect of Omega-3 Fatty Acids Supplementation on Depressive Symptoms and on Health-Related Quality of Life in the Treatment of Elderly Women with Depression: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial
Mariangela Rondanelli et al.
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION (2010)
Ethyl-eicosapentaenoic acid for the treatment of psychological distress and depressive symptoms in middle-aged women: a double-blind, placebo-controlled, randomized clinical trial
Michel Lucas et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2009)
No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function:: a randomised controlled trial
Peter J. Rogers et al.
BRITISH JOURNAL OF NUTRITION (2008)
Fish oil supplementation in the treatment of major depression: A randomised double-blind placebo-controlled trial
Brin F. S. Grenyer et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2007)
Omega-3 fatty acids in major depressive disorder - A preliminary double-blind, placebo-controlled trial
KP Su et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2003)
Share Paper
